Literature DB >> 3770945

Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice.

J Brajtburg, S Elberg, G S Kobayashi, G Medoff.   

Abstract

Amphotericin B (AmB) treatment before infection with the bacterium Listeria monocytogenes prolonged survival of AKR mice but shortened survival of C57BL/6 mice compared with survival of untreated infected controls. C57BL/6 mice were also more sensitive to the acute toxic effects of AmB than AKR mice, as were (C57BL/6 X AKR)F1 hybrid mice. Spleen cells and erythrocytes (RBCs) from the C57BL/6 and the F1 hybrid mice were both more sensitive to the lytic and lethal effects of AmB than corresponding cells from AKR mice. Biochemical analysis indicated that catalase levels in RBCs from C57BL/6 and F1 hybrid mice were about 60% of those found in RBCs from AKR mice. The lysis by AmB of RBCs from all these strains of mice was inhibited by catalase or incubation in a low-oxygen environment. These findings suggest that (i) the low catalase levels in C57BL/6 and F1 hybrid mice may limit the protection of cells from the oxidant damage involved in AmB action, and (ii) the toxicity which occurs at low concentrations of AmB in the mouse strains with low intracellular catalase levels may interfere with or ablate the AmB-induced increases in mouse resistance to L. monocytogenes infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3770945      PMCID: PMC260160          DOI: 10.1128/iai.54.2.303-307.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  IMPROVED PROCEDURE FOR THE EXTRACTION OF LIPIDS FROM HUMAN ERYTHROCYTES.

Authors:  H G ROSE; M OKLANDER
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

2.  Augmentation of murine immune responses by amphotericin B.

Authors:  T J Blanke; J R Little; S F Shirley; R G Lynch
Journal:  Cell Immunol       Date:  1977-09       Impact factor: 4.868

3.  Changes in murine resistance to Listeria monocytogenes infection induced by amphotericin B.

Authors:  M Z Thomas; G Medoff; G S Kobayashi
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

4.  Erythrocyte catalase in inbred mice.

Authors:  H A Hoffman; M Rechcigl
Journal:  Enzyme       Date:  1971

5.  The estimation of red cell superoxide dismutase activity.

Authors:  C C Winterbourn; R E Hawkins; M Brian; R W Carrell
Journal:  J Lab Clin Med       Date:  1975-02

Review 6.  Myocardial ischemia: ionic events in ischemia and anoxia.

Authors:  K I Shine
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

7.  Cellular basis for genetically determined enhanced resistance of certain mouse strains to listeriosis.

Authors:  C Sadarangani; E Skamene; P A Kongshavn
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

8.  Sterol to phospholipid molar ratios of L cells with qualitative and quantitative variations of cellular sterol.

Authors:  L Sokoloff; G H Rothblat
Journal:  Proc Soc Exp Biol Med       Date:  1974-09

9.  Amphotericin B-induced resistance to Schistosoma mansoni.

Authors:  G R Olds; S J Stewart; J J Ellner
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

10.  Immunopotentiating effects of amphotericin B. I. Enhanced contact sensitivity in mice.

Authors:  S F Shirley; J R Little
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

View more
  8 in total

Review 1.  In vitro models for studying toxicity of antifungal agents.

Authors:  V Joly; J Bolard; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

Authors:  Bidyut Purkait; Ashish Kumar; Nilay Nandi; Abul Hasan Sardar; Sushmita Das; Sudeep Kumar; Krishna Pandey; Vidyananda Ravidas; Manish Kumar; Tripti De; Dharmendra Singh; Pradeep Das
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

3.  Effects of MS-8209, an amphotericin B derivative, on tumor necrosis factor alpha synthesis and human immunodeficiency virus replication in macrophages.

Authors:  P Clayette; M Martin; V Beringue; N Dereuddre-Bosquet; K T Adjou; M Seman; D Dormont
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products.

Authors:  Jon A Olson; Jill P Adler-Moore; Gerard M Jensen; Julie Schwartz; M Cecilia Dignani; Richard T Proffitt
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

Review 5.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.

Authors:  M Larabi; P Legrand; M Appel; S Gil; M Lepoivre; J Devissaguet; F Puisieux; G Barratt
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 7.  New challenges to the therapy of systemic fungal infections.

Authors:  G Medoff
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

8.  Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.

Authors:  E Martin; A Stüben; A Görz; U Weller; S Bhakdi
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.